These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30186491)

  • 21. Apolipoprotein B-100 peptide 210 antibody inhibits atherosclerosis by regulation of macrophages that phagocytize oxidized lipid.
    Zeng Z; Cao B; Guo X; Li W; Li S; Chen J; Zhou W; Zheng C; Wei Y
    Am J Transl Res; 2018; 10(6):1817-1828. PubMed ID: 30018722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leonurine Prevents Atherosclerosis Via Promoting the Expression of ABCA1 and ABCG1 in a Pparγ/Lxrα Signaling Pathway-Dependent Manner.
    Jiang T; Ren K; Chen Q; Li H; Yao R; Hu H; Lv YC; Zhao GJ
    Cell Physiol Biochem; 2017; 43(4):1703-1717. PubMed ID: 29045950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. microRNA-212 promotes lipid accumulation and attenuates cholesterol efflux in THP-1 human macrophages by targeting SIRT1.
    Miao H; Zeng H; Gong H
    Gene; 2018 Feb; 643():55-60. PubMed ID: 29174964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isoliquiritigenin Attenuates Atherogenesis in Apolipoprotein E-Deficient Mice.
    Du F; Gesang Q; Cao J; Qian M; Ma L; Wu D; Yu H
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The dipeptidyl peptidase-IV inhibitor inhibits the expression of vascular adhesion molecules and inflammatory cytokines in HUVECs via Akt- and AMPK-dependent mechanisms.
    Hwang HJ; Chung HS; Jung TW; Ryu JY; Hong HC; Seo JA; Kim SG; Kim NH; Choi KM; Choi DS; Baik SH; Yoo HJ
    Mol Cell Endocrinol; 2015 Apr; 405():25-34. PubMed ID: 25661535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice.
    Hasan ST; Zingg JM; Kwan P; Noble T; Smith D; Meydani M
    Atherosclerosis; 2014 Jan; 232(1):40-51. PubMed ID: 24401215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammation inhibition and gut microbiota regulation by TSG to combat atherosclerosis in ApoE
    Li F; Zhang T; He Y; Gu W; Yang X; Zhao R; Yu J
    J Ethnopharmacol; 2020 Jan; 247():112232. PubMed ID: 31606534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amygdalin ameliorates the progression of atherosclerosis in LDL receptor‑deficient mice.
    Lv J; Xiong W; Lei T; Wang H; Sun M; Hao E; Wang Z; Huang X; Deng S; Deng J; Wang Y
    Mol Med Rep; 2017 Dec; 16(6):8171-8179. PubMed ID: 28983592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Polydatin inhibits cell proliferation and expressions of inflammatory cytokines in THP-1 cells induced by ox-LDL via up-regulating SIRT1].
    Ma Y; Ruan Y; Wang Y; Wu S
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Mar; 34(3):193-198. PubMed ID: 29773098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stanozolol promotes lipid deposition in the aorta through an imbalance in inflammatory cytokines and oxidative status in LDLr knockout mice fed a normal diet.
    de Andrade TU; Haguihara SCGC; Falsoni RMP; da Silva CL; Dubois Filho DG; de Souza Andrade Moraes F; do Nascimento AM; Brasil GA; de Lima EM
    Basic Clin Pharmacol Toxicol; 2019 Apr; 124(4):360-369. PubMed ID: 30295413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attenuation of early atherogenesis in low-density lipoprotein receptor-deficient mice by proteasome inhibition.
    Wilck N; Fechner M; Dreger H; Hewing B; Arias A; Meiners S; Baumann G; Stangl V; Stangl K; Ludwig A
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1418-26. PubMed ID: 22516063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis.
    Clinton SK; Underwood R; Hayes L; Sherman ML; Kufe DW; Libby P
    Am J Pathol; 1992 Feb; 140(2):301-16. PubMed ID: 1739124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway.
    Tang ZH; Peng J; Ren Z; Yang J; Li TT; Li TH; Wang Z; Wei DH; Liu LS; Zheng XL; Jiang ZS
    Atherosclerosis; 2017 Jul; 262():113-122. PubMed ID: 28535426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of soluble epoxide hydrolase alleviated atherosclerosis by reducing monocyte infiltration in Ldlr(-/-) mice.
    Li D; Liu Y; Zhang X; Lv H; Pang W; Sun X; Gan LM; Hammock BD; Ai D; Zhu Y
    J Mol Cell Cardiol; 2016 Sep; 98():128-37. PubMed ID: 27496380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salusin-α attenuates hepatic steatosis and atherosclerosis in high fat diet-fed low density lipoprotein receptor deficient mice.
    Tang K; Wang F; Zeng Y; Chen X; Xu X
    Eur J Pharmacol; 2018 Jul; 830():76-86. PubMed ID: 29704496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
    Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrophage ABCG1 deletion disrupts lipid homeostasis in alveolar macrophages and moderately influences atherosclerotic lesion development in LDL receptor-deficient mice.
    Out R; Hoekstra M; Hildebrand RB; Kruit JK; Meurs I; Li Z; Kuipers F; Van Berkel TJ; Van Eck M
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2295-300. PubMed ID: 16857950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gua Lou Er Chen decoction attenuates atherosclerosis by reducing proteoglycans accumulation and inflammation.
    Guo H; Li Y; Qiu L; Li J; Guo X; Zhang Y; Wang J
    Phytomedicine; 2023 Jul; 115():154811. PubMed ID: 37094421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-tumor necrosis factor-α therapy increases plaque burden in a mouse model of experimental atherosclerosis.
    Oberoi R; Vlacil AK; Schuett J; Schösser F; Schuett H; Tietge UJF; Schieffer B; Grote K
    Atherosclerosis; 2018 Oct; 277():80-89. PubMed ID: 30176568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of miR-467b on lipoprotein lipase (LPL) expression, pro-inflammatory cytokine, lipid levels and atherosclerotic lesions in apolipoprotein E knockout mice.
    Tian GP; Tang YY; He PP; Lv YC; Ouyang XP; Zhao GJ; Tang SL; Wu JF; Wang JL; Peng J; Zhang M; Li Y; Cayabyab FS; Zheng XL; Zhang DW; Yin WD; Tang CK
    Biochem Biophys Res Commun; 2014 Jan; 443(2):428-34. PubMed ID: 24309104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.